Stromal senescence and response to immune checkpoint inhibition in melanoma

被引：0
|
作者：
Sojo, Giselle Burton
Schmidt, Marcel O.
机构：
来源：
CANCER IMMUNOLOGY RESEARCH | 2025年 / 13卷 / 02期
关键词：
D O I：
10.1158/2326-6074.IO2025-B047
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B047
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A prediction model for response to immune checkpoint inhibition in advanced melanoma
    van Duin, Isabella A. J.
    Verheijden, Rik J.
    van Diest, Paul J.
    Blokx, Willeke A. M.
    El-Sharouni, Mary-Ann
    Verhoeff, Joost J. C.
    Leiner, Tim
    van den Eertwegh, Alfonsus J. M.
    de Groot, Jan Willem B.
    van Not, Olivier J.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette W. P. J.
    Blank, Christian U.
    Haanen, John B. A. G.
    Hospers, Geke A. P.
    Piersma, Djura
    van Rijn, Rozemarijn S.
    van Der Veldt, Astrid A. M.
    Vreugdenhil, Gerard
    Wouters, Michel W. J. M.
    Stevense-den Boer, Marion A. M.
    Boers-Sonderen, Marye J.
    Kapiteijn, Ellen
    Suijkerbuijk, Karijn P. M.
    Elias, Sjoerd G.
    INTERNATIONAL JOURNAL OF CANCER, 2024, 154 (10) : 1760 - 1771
  • [2] Tumor characteristics of dissociated response to immune checkpoint inhibition in advanced melanoma
    Versluis, J. M.
    Hoefsmit, E. P.
    Shehwana, H.
    Dimitriadis, P.
    Sanders, J.
    Broeks, A.
    Blank, C. U.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (02)
  • [3] A prediction model for response to immune checkpoint inhibition in advanced melanoma.
    van Duin, Isabella A. J.
    Verheijden, Rik Jasper
    van Diest, Paul J.
    van den Eertwegh, Alfonsus Johannes Maria
    de Groot, Jan Willem
    van Not, Olivier Jules
    Aarts, Maureen J. B.
    Van den Berkmortel, Franchette
    Blank, Christian U.
    Haanen, John B. A. G.
    Hospers, Geke
    Piersma, Djura
    van Rijn, Rozemarijn
    Van der Veldt, Astrid Aplonia Maria
    Vreugdenhil, Gerard
    Stevense-den Boer, Marion
    Boers-Sonderen, Marye J.
    Kapiteijn, Ellen
    Suijkerbuijk, Karijn
    Elias, Sjoerd G.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Tumor characteristics of dissociated response to immune checkpoint inhibition in advanced melanoma
    J. M. Versluis
    E. P. Hoefsmit
    H. Shehwana
    P. Dimitriadis
    J. Sanders
    A. Broeks
    C. U. Blank
    Cancer Immunology, Immunotherapy, 73
  • [5] Response and outcome of patients with melanoma skin metastases and immune checkpoint inhibition
    Forschner, Andrea
    Nanz, Lena
    Maczey-Leber, Yves
    Amaral, Teresa
    Flatz, Lukas
    Leiter, Ulrike
    INTERNATIONAL JOURNAL OF CANCER, 2025, 156 (01) : 145 - 153
  • [6] Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition
    Alvarez-Breckenridge, Christopher
    Markson, Samuel C.
    Stocking, Jackson H.
    Nayyar, Naema
    Lastrapes, Matt
    Strickland, Matthew R.
    Kim, Albert E.
    de Sauvage, Magali
    Dahal, Ashish
    Larson, Juliana M.
    Mora, Joana L.
    Navia, Andrew W.
    Klein, Robert H.
    Kuter, Benjamin M.
    Gill, Corey M.
    Bertalan, Mia
    Shaw, Brian
    Kaplan, Alexander
    Subramanian, Megha
    Jain, Aarushi
    Kumar, Swaminathan
    Danish, Husain
    White, Michael
    Shahid, Osmaan
    Pauken, Kristen E.
    Miller, Brian C.
    Frederick, Dennie T.
    Hebert, Christine
    Shaw, McKenzie
    Martinez-Lage, Maria
    Frosch, Matthew
    Wang, Nancy
    Gerstner, Elizabeth
    Nahed, Brian, V
    Curry, William T.
    Carter, Bob
    Cahill, Daniel P.
    Boland, Genevieve Marie
    Izar, Benjamin
    Davies, Michael A.
    Sharpe, Arlene H.
    Suva, Mario L.
    Sullivan, Ryan J.
    Brastianos, Priscilla K.
    Carter, Scott L.
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (08) : 996 - 1012
  • [7] Targeting metabolism to improve response to immune-checkpoint inhibition in melanoma.
    Tiersma, Jiske F.
    Evers, Bernard
    Bakker, Barbara M.
    de Jong, Steven
    Jalving, Mathilde
    CANCER RESEARCH, 2020, 80 (23)
  • [8] The influence of hematologic malignancies on response to immune checkpoint inhibition in patients with advanced melanoma
    van Not, O. J.
    Van Den Eertwegh, F.
    Haanen, J. B. A. G.
    van Rijn, R. S.
    Aarts, M.
    Van den Berkmortel, F.
    Blank, C. U.
    Boers-Sonderen, M.
    de Groot, J. W. B.
    Hospers, G.
    Kapiteijn, E.
    De Meza, M. M.
    Piersma, D.
    Stevense-den Boer, M.
    Van der Veldt, A. A. M.
    Vreugdenhil, G.
    Wouters, M.
    Blokx, W. A. M.
    Suijkerbuijk, K. P. M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S942 - S943
  • [9] Response to BRAF Inhibition in Melanoma Is Enhanced When Combined with Immune Checkpoint Blockade
    Cooper, Zachary A.
    Juneja, Vikram R.
    Sage, Peter T.
    Frederick, Dennie T.
    Piris, Adriano
    Mitra, Devarati
    Lo, Jennifer A.
    Hodi, Stephen
    Freeman, Gordon J.
    Bosenberg, Marcus W.
    McMahon, Martin
    Flaherty, Keith T.
    Fisher, David E.
    Sharpe, Arlene H.
    Wargo, Jennifer A.
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (07) : 643 - 654
  • [10] Baseline tumor-infiltrating lymphocytes and response to immune checkpoint inhibition in advanced melanoma
    Schuiveling, M.
    van Duin, I.
    ter Maat, L. S.
    Van den Berkmortel, F. W. P. J.
    Boers-Sonderen, M. J.
    de Groot, J. W.
    Kapiteijn, E.
    Labots, M.
    Piersma, D.
    Schrader, A. M. R.
    Vreugdenhil, G.
    Westgeest, H. M.
    Pluim, J.
    Veta, M.
    Blokx, W. A.
    van Diest, P. J.
    Suijkerbuijk, K. P. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S675 - S675
12345